GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a significant focus in therapeutic studies, largely due to its impressive impact on controlling diseases such as adult-onset diabetes and excess body fat. New research have demonstrated that more than glucose control, GLP-1 agonists offer promise for heart well-being and